Newron Pharmaceuticals S.p.A. (SWX:NWRN)
6.67
+0.13 (1.99%)
Apr 4, 2025, 10:39 AM CET
Newron Pharmaceuticals Revenue
In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M EUR with 467.41% growth. Newron Pharmaceuticals had revenue of 3.41M in the half year ending June 30, 2024, with 20.39% growth.
Revenue
51.39M EUR
Revenue Growth
+467.41%
P/S Ratio
2.53
Revenue / Employee
2.34M EUR
Employees
22
Market Cap
130.53M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.39M | 42.33M | 467.41% |
Dec 31, 2023 | 9.06M | 2.96M | 48.62% |
Dec 31, 2022 | 6.09M | 332.00K | 5.76% |
Dec 31, 2021 | 5.76M | 504.00K | 9.59% |
Dec 31, 2020 | 5.26M | -1.78M | -25.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Alcon | 8.98B |
Lonza Group AG | 6.57B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.41B |
Sonova Holding AG | 3.71B |
Newron Pharmaceuticals News
- 2 days ago - Newron Pharmaceuticals reports FY results - Seeking Alpha